Browse: Home / News Release: Longfellow Launches Via Labs Branding & Vision at Hub RTP Project with Upcoming Life Science Development / Page 42

News Release: Longfellow Launches Via Labs Branding & Vision at Hub RTP Project with Upcoming Life Science Development

News Release: Longfellow Launches Via Labs Branding & Vision at Hub RTP Project with Upcoming Life Science Development

By on September 21, 2023

Longfellow is set to develop more than 265,000 square feet of lab and office space within the revolutionary campus

Research Triangle, NC (September 21, 2023) – Longfellow Real Estate Partners, the largest privately held investor and developer of life science buildings, unveiled Via Labs at Hub RTP as the new name and brand of its life science development that is currently underway at the revolutionary Hub RTP project in the Research Triangle.

This marquee building and innovative development located on a 1.5-acre lot will be part of Research Triangle Park’s two million square foot master planned development that will continue to transform RTP from a corporate campus into a true live-work-play ecosystem that will cater to the needs of leading international companies.

The 265,000 square foot project will feature Class A life science and innovative space that will showcase the growth of the Research Triangle and double down on Longfellow’s commitment to invest in and support the life science industry in North Carolina.

“Seeing the vision of Via Labs come to life along with the new brand is truly exciting,” said Greg Capps, Managing Director at Longfellow Real Estate Partners. “Our team is committed to supporting the life science industry and ecosystem as well as tremendous community projects such as Hub RTP – the vision and impact of this project will be seen for generations to come in the Research Triangle.”

The Via Labs project stands to be a connection between the proud history of innovation in the Research Triangle and the possibilities of tomorrow. By serving the active and robust life science demand in the Research Triangle, this location will deliver on Longfellow’s vision to provide state-of-the-art lab space combined with neighborhood feel and high-quality community amenities. Longfellow will also implement the company’s proprietary tenant experience platform ElevateTM, which will build off the local offerings and incorporate on-site facilities through custom programming to heighten the campus experience for future tenants and community members.

“Working with a highly sought after company like Longfellow Real Estate Partners validates the strength of Hub RTP, Research Triangle Park’s new vibrant downtown,” said Scott Levitan, President and CEO of the Research Triangle Foundation of NC. “Including this life science development continues to build out the masterplan that supports the office, retail, hotel, and residential components in a holistic way.”

Longfellow has spearheaded the development of life science clusters throughout the region, including key campuses located in Wake County, Research Triangle Park, and Downtown Durham. With more than 16.5 million square feet located in key biotech markets across the United States and United Kingdom, Longfellow continues to partner with and support innovative companies and institutions in the leading metro regions.

For additional information and leasing inquiries regarding the Via Labs development, please visit: www.ViaLabsatHubRTP.com.

###

Posted in ,

News Release: Newmark Closing Announcement — Multi-City Florida

By on September 21, 2023

Posted in , ,

News Release: HED Shares Its Design of the Perceptive Real Estate Equities, Inc – Ardenwood Innovation and Life Sciences Center and Hub for Biotech and Life Science Companies

By on September 21, 2023

September 21, 2023

HED Shares Its Design of the Perceptive Real Estate Equities, Inc – Ardenwood Innovation and Life Sciences Center and Hub for Biotech and Life Science Companies, Located within the Renowned Ardenwood Technology Park in Fremont, CA

HED has revealed the design of the second phase of the Ardenwood Innovation and Life Sciences Center expansion, adding a new 75,000 square foot facility to its existing 100,000 square foot built-to-suit for cancer genomics company, Personalis, Inc. who occupied their corporate headquarters and laboratory facility in October of last year.

With central access to airports, freeways, research and higher education facilities, a strong supply chain of services providers, and supportive zoning, Fremont, CA has positioned itself as a hub of biomedical investment in Northern California. A few short years ago, the city recently received a federal grant to build an East Bay biomedical manufacturing cluster, and The Biomedical Manufacturing Network, a three-year program designed to boost the region’s strength in the biotech industry, has strengthened Fremont’s reputation as a prime location for companies to scale operations with relative ease.

This building will be a new addition to the existing site and will expand Perceptive Real Estate Equities, Inc’s life science offerings by an additional 75,000 SF two-story life sciences building. The new building will be positioned adjacent to an existing 100,000 SF Personalis, Inc. laboratory and headquarters facility, offering the opportunity for a single tenant to occupy the 75,000 SF expansion building or for multiple tenants to be spread across the building with strategic adjacencies of parking and shared outdoor amenities.

“The design represents an exciting and refreshing environment that, while fitting with the context of the area, enhances the site by transforming it from a single building into a compelling campus,” says Tim Schulze, AIA, NCARB, Sector Leader with HED, “The new building is treated similarly in scale and feel with others in the area, while carefully articulating corners and certain areas that give it a true street presence. The front façade and mass are carefully broken and layered to spark interest when approaching from the street, and a shared outdoor amenity area complements the structure and serves as a buffer zone to the building and the campus while bringing all the energy from future tenants outside.”

The new structure has been envisioned with a modern exterior curtain wall, ACM panels and multi-faceted exposed pre-cast concrete panels highlighted with Formliner and sandblasted elements. The first floor possesses a height of 17’ floor to floor while the second floor is 16’ floor to roof. This will also allow for 11’ ceilings, 11’ vision glass for daylighting and robust building systems to accommodate future laboratory needs. HED provided full-service planning, architectural and engineering, and landscape design services for the project.

Perceptive Real Estate Equities, Inc was spun off and formed by its Founder and CEO Mark Pearson, who is also Drawbridge Realty’s Co-Founder and Vice Chairman of the Board. Perceptive Real Estate Equities, Inc’s charter is to focus on development and redevelopment of projects deemed more speculative in nature and do not fit the current Drawbridge Realty profile.

Posted in ,

News Release: Breakthrough Properties to Develop New European Headquarters for Neogene Therapeutics

By on September 21, 2023

NEWS PROVIDED BY Breakthrough Properties

21 Sep, 2023, 12:31 ET

Breakthrough Expands its International Footprint, Entering the Burgeoning Amsterdam Life Science Community in Partnership with the Amsterdam University Medical Center

Anticipated to be One of the World’s Most Advanced and Sustainable Laboratory Environments, Kavel F by Breakthrough Aims to Achieve Carbon Negative Operations and a BREEAM Outstanding Rating

Kavel F by Breakthrough

AMSTERDAM, Sept. 21, 2023 /PRNewswire/ — Breakthrough Properties, a premier global life sciences real estate developer, announced that it has reached an agreement with Neogene Therapeutics to develop its new European headquarters within the campus of the Amsterdam University Medical Center (Amsterdam UMC), one of Europe’s leading medical institutions.

Neogene Therapeutics (Neogene), a wholly owned subsidiary of global biopharmaceutical company AstraZeneca, is a clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers.

Breakthrough, a joint venture of Tishman Speyer and Bellco Capital, acquired the development site from Amsterdam UMC after a highly competitive bidding process, executed the 100% pre-lease to Neogene, and broke ground on the five-story development in August. Breakthrough is creating a state-of-the-art biotech research facility that will be fully occupied by Neogene upon its completion in the summer of 2025.

Kavel F by Breakthrough (Kavel F) is destined to become one of the most sustainable laboratory environments in the world. Designed to BREEAM Outstanding certification standards, the all-electric building will layer sustainable technologies to maintain Net Zero Emissions in the energy performance model and is expected to contribute energy back into the electrical grid under normal operating conditions. Key technologies include geothermal storage for sustainable heating and cooling, highly efficient air treatment, PV panels, and phase shift climate ceilings.

“Breakthrough is thrilled to support the Neogene team as it aims to bring the potential benefits of T cell receptor therapies to more patients with cancer,” said Breakthrough Properties Chief Executive Officer and Co-Founder Dan Belldegrun. “Kavel F is emblematic of Breakthrough Properties’ mission to support cutting edge science by delivering high-quality, sustainable environments.”

“As we continue our efforts to pioneer T cell receptor therapies, we are excited to support our further growth in Amsterdam by developing a state-of-the-art R&D building together with Breakthrough Properties, Amsterdam UMC and the City of Amsterdam,” commented Carsten Linnemann, Ph.D., Chief Executive Officer and Co-Founder of Neogene Therapeutics. “The building will enhance our research and development by providing a modern, collaborative work environment that meets the highest sustainability standards.”

The Amsterdam market continues to develop into one of Europe’s most prominent life science hubs, offering proximity to several of Europe’s leading research and medical institutions such as the Amsterdam UMC, a deep pool of life science talent and biopharma companies, and the European Medicines Agency following its relocation from the UK in 2019. Kavel F is a key component in the city of Amsterdam’s efforts to support the continued growth of the surrounding cluster on the campus of the Amsterdam UMC. The master plan calls for one million square feet of new development across seven sites that will enable collaboration on bold, patient-centric initiatives.

Prof. Dr. Hans van Goudoever, dean and vice chair of the executive board of Amsterdam UMC said, “Amsterdam UMC is thrilled to have Breakthrough Properties and Neogene as next-door partners. Front running medicine development in a sustainable environment fits perfectly within the scope of Amsterdam UMC as one of Europe’s top medical institutes. It is a valuable addition to our Medical Business Park and the Amsterdam Life Science District. We are looking forward bringing together innovation, healthcare and science, all for the benefit of our patients – for now and in the future.”

Breakthrough promotes sustainability, biodiversity and occupant health and wellness throughout all their projects. Kavel F by Breakthrough will feature an ultra-high performing, triple-glazed glass façade and incorporate a series of landscaped outdoor terraces, architectural solar shades and green roofs featuring local plant varieties and biophilic materials. Breakthrough will also install electric vehicle charging infrastructure and bicycle storage areas, tapping into Amsterdam’s vast cycling network and most preferred method of commuting.

“We are grateful to the Amsterdam University Medical Center for this opportunity to contribute to a thriving campus that brings together clinicians, scientists, researchers, entrepreneurs and companies on efforts to dramatically improve patient outcomes in the clinical care environment,” said Thomas Renn, Breakthrough Properties Vice President of Acquisitions and Development for Europe. “Breakthrough is pleased to bring our expertise to Amsterdam, and we look forward to complementing its thriving life sciences sector.”

Reinier van Dantzig, Deputy Mayor of the City of Amsterdam, said, “The municipality of Amsterdam is delighted that this development is starting. This sustainable building reflects the high ambitions that we, together with the Amsterdam UMC, have set for this area. The building and the future users give an impulse to the medical technological development as well as to the further development of this innovation district. This innovative area offers space for collaboration and knowledge exchange with a focus on health. The expansion of laboratory capacity at the park responds to the growing demand for laboratory space. The science at this location makes an important contribution to future healthcare in Amsterdam and beyond. We have enjoyed working with Breakthrough, the result is to be proud of.”

Breakthrough has retained the Dutch construction firm De Vries en Verburg to serve as general contractor on the project and award-winning architecture design network UNStudio.

Breakthrough currently has more than five million square feet in its under-construction and development pipeline across Europe and the United States. Among recent and ongoing development projects are The 105 by Breakthrough in Boston, home to CRISPR Therapeutics’ U.S. R&D headquarters; the 10-acre Torrey View by Breakthrough campus, which will be anchored by a new innovation center for Becton, Dickinson and Company (BD); Trinity by Breakthrough in Oxford, England; and Vitrum by Breakthrough, located on 1.8 acres inside St John’s Innovation Park in Cambridge, England.

About Breakthrough Properties (www.btprop.com)
Formed in 2019 as a joint venture between global real estate owner, developer and investor Tishman Speyer and biotechnology investment firm Bellco Capital, Breakthrough Properties is a life science real estate development company that leverages cross-sector collaboration to deliver environments that foster innovation and scientific breakthroughs. Breakthrough Properties’ mission is to acquire, develop and operate the best life science properties in leading urban technology centers around the world and support scientific innovation across biotechnology, agriculture and nutrition. Breakthrough combines Tishman Speyer’s decades of global real estate development experience with Bellco Capital’s industry-making biotechnology entrepreneurship to reimagine environments where companies can create life-changing therapies for patients.

SOURCE Breakthrough Properties

Posted in ,

News Release: Anchor Health Properties Celebrates Groundbreaking of Tampa General Hospital’s New Behavioral Health Hospital

By on September 21, 2023

(Tampa, FL), Sept. 21, 2023 – Building upon the company’s proven track record of delivering dynamic, patient-centric healthcare facilities in the Tampa Bay area, Anchor Health Properties (Anchor), a national, full-service healthcare real estate development, management and investment company focused exclusively on medical facilities, recently celebrated the groundbreaking of a new four-story inpatient behavioral health hospital measuring approximately 83,000 square feet with 96 to 120 inpatient beds. Continuing upon the successful delivery of the adjacent TGH Rehabilitation Hospital in 2022, Tampa General Hospital (TGH) and Lifepoint Health have directly engaged Anchor as the fee-for-service developer on this project.

The new hospital, located adjacent to downtown Tampa, is a joint-venture relationship between Tampa General Hospital and Lifepoint Behavioral Health, a business unit of Lifepoint Health, and will meet the increasing demand for mental health services in the community while serving as an integral part of the growing Tampa Medical and Research District.

 

Strategically positioned adjacent to the TGH Rehabilitation Hospital, also developed by Anchor Health Properties, services within the facility will provide compassionate, comprehensive and intensive psychiatric treatment to children, adolescents, adults and seniors experiencing behavior and mental health conditions, especially those with complex conditions.

 

“This groundbreaking is a culmination of efforts by many people and is a testament to how a community can work together to achieve great success,” said Will Foster, Senior Development Director with Anchor. “We are excited to have been engaged again by Tampa General Hospital and Lifepoint Health to support their efforts in expanding Tampa’s Medical and Research District through delivery of much needed behavioral health services while strengthening the standard of care in the community.”

 

Tampa General Hospital will provide a number of facility and medical support services, while Lifepoint Behavioral Health will manage the day-to-day operations. Physicians with the Department of Psychiatry and Behavioral Neurosciences in the USF Health Morsani College of Medicine will provide a full range of inpatient and outpatient care in specialized units for pediatrics, adolescents, adults and geriatrics.

 

Regionally based firms with extensive healthcare facility experience are serving on the project team, including Stengel-Hill Architecture, a leading design firm in the behavioral healthcare industry, and JE Dunn Construction, one of the nation’s top 10 largest healthcare builders.

 

The facility is slated to open to patients in 2024.

 

About Anchor Health Properties

Anchor Health Properties is a national, full-service healthcare real estate development, management and investment firm serving investors and health systems. Leveraging our collective experience and resources, our nimble, and thoughtful team of professionals develops and delivers tailored, client-specific solutions to respond to today’s healthcare challenges – thinking outside the “medical office box.” With more than $2B of completed development projects, 9M square feet under management, and $3.2B invested in stabilized healthcare facilities, Anchor continues to create a better healthcare experience for patients and a competitive edge for our clients. Anchor maintains multiple offices nationwide and features more than 100 professionals in its ranks. Healthcare today calls not only for new and more efficient ways of delivering healthcare services, but also a different kind of healthcare real estate company. For more information, please visit: www.anchorhealthproperties.com.

 

 

###

Posted in , , ,

News Release: RYAN COMPANIES COMPLETES PRAIRIECARE YOUTH AND YOUNG ADULT PSYCHIATRIC HOSPITAL EXPANSION AHEAD OF SCHEDULE

By on September 21, 2023

Early completion allows PrairieCare to accommodate the additional needs for hospital beds in September

 

BROOKLYN PARK, Minn. (Sept. 21, 2023) – After breaking ground in August 2022, Ryan Companies US, Inc. – a national commercial real estate solutions provider – announces the completion of PrairieCare’s youth and young adult psychiatric inpatient hospital expansion. Finishing three weeks ahead of schedule, PrairieCare – one of the nation’s most innovative and fastest-growing psychiatric health systems – can begin serving more youth and young adults during a month where there is historically an increased need.

“We remain in a national mental health crisis that is disproportionately affecting youth, and this much needed expansion will address the critical needs of hundreds of families in Minnesota each year,” said Todd Archbold, CEO of PrairieCare. “PrairieCare was proud to partner with Ryan Companies on another successful project, completed ahead of schedule in response to the increased demand for inpatient psychiatric care.”

The nearly 30,000-square-foot expansion includes an additional 30 inpatient beds, activity and therapy spaces, allowing PrairieCare to serve an additional 1,000 youth and young adults each year. This marks the largest increase of psychiatric beds for youth in the state in decades. The newly expanded hospital is adjacent to 610 Medical Center, the two-story medical office building which houses PrairieCare, PrairieCare Medical Group, and the PrairieCare Foundation. 610 Medical Center was developed and built by Ryan, and designed by Ryan A+E, Inc.

“More than six years after celebrating the grand opening of 610 Medical Center with PrairieCare, we are absolutely thrilled to be celebrating again with their new, inpatient expansion,” said Tony Barranco, North region president, Ryan Companies. “The impact these additional beds will have for Minnesota youth and young adults will be profound and, we are so proud to be part of this fantastic project.”

The grand opening ceremony took place Sept. 20, which included a ribbon cutting and tour.

Ryan built the expansion. Pope Architects served as the architect and interior designer for the project.

The PrairieCare expansion marks more than 1,000,000 square feet built by Ryan in Brooklyn Park since 2016. Other projects Ryan constructed in the area include Kurita Water Industries and 610 Zane East & West.

 

About PrairieCare

PrairieCare, a division of Newport Healthcare, is one of the nation’s most innovative, fastest-growing psychiatric health systems, offering psychiatric services for all ages, including free mental health screenings, clinic services, intensive outpatient programs (IOP), partial hospital programs (PHP), residential services, and an inpatient psychiatric hospital. PrairieCare is based in Minnesota, with nine locations across the Twin Cities metro area, Mankato and Rochester. For more information about services offered, visit prairie-care.com.

 

About Ryan Companies US, Inc.

Founded in 1938, Ryan Companies offers comprehensive commercial real estate services as a national developer, designer, builder, capital markets advisor and real estate manager with a focus on creating places for people to thrive. Ryan work spans a wide range of sectors and product types including healthcare, hospitality, industrial, mixed-use, multifamily, office, retail, and senior living. Built on the foundation of integrity, honesty and community, Ryan has grown to nearly 2,000 team members in 17 offices and has completed projects in almost every state. For more information, visit ryancompanies.com. 

###

Posted in , , ,

News Release: H2C Executes $67M Bridge Loan for Senior Living Owner/Operator

By on September 21, 2023

NEW YORK — H2C Securities Inc. (“H2C”), a healthcare-focused strategic advisory and investment banking firm, served as the exclusive advisor to Quality Life Services (“QLS” or “Company”) in the execution of a bridge loan to refinance the debt associated with the Company’s portfolio of 10 skilled nursing and senior living facilities (the “Properties”).

The effects of the pandemic on the senior living sector caused many banks, along with the Company’s lenders, to reduce their exposure to the long-term care sector and resulted in the need for QLS to refinance its outstanding debt. With the continuation of its mission the most important objective, QLS retained H2C to assist in evaluating a range of strategic and financing options for the Company. H2C assembled a team of professionals with expertise in the capital markets, mergers and acquisitions, and healthcare real estate to identify and evaluate alternatives that would ensure access to quality care for QLS’ communities. H2C conducted in-depth analyses of each option and negotiated with various parties to improve the terms and conditions of each option. QLS ultimately elected to execute a bridge-to-HUD loan for the Properties, allowing the Company to retain control and prepare to secure lower cost long-term financing via HUD in the future.

Locations
ATLANTA
3344 Peachtree Road Northeast
Suite 900
Atlanta, GA 30326
404-937-1350		 CHICAGO
222 S. Riverside Plaza
32nd Floor
Chicago, IL 60606
312-508-4200
NEW YORK
50 Rockefeller Plaza
Suite 1101
New York, NY 10020
212-257-4500		 SAN DIEGO
4655 Executive Drive
Suite 280
San Diego, CA 92121
858-242-4800

About H2C Securities Inc. (“H2C”)

H2C is a strategic advisory and investment banking firm committed to providing superior advice to public and private healthcare and higher education institutions and related organizations throughout the United States. H2C’s professionals have a long track record of success in mergers and acquisitions, capital markets, and real estate transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value.

Securities and services offered through H2C Securities Inc., member FINRA / SIPC a registered broker-dealer and an indirect subsidiary of Fifth Third Bank, National Association. All rights reserved. Securities and services offered through H2C Securities Inc.: Are Not FDIC Insured; Offer No Bank Guarantee; May Lose Value; Are Not Insured by any Federal Government Agency; Are Not a Deposit.

For more information, visit h2c.com.

About Fifth Third Capital Markets
Fifth Third Capital Markets is the marketing name under which Fifth Third Bank, National Association, and/or its subsidiaries, H2C Securities Inc. and Fifth Third Securities, Inc., provide certain securities and investment banking products and services. Fifth Third Capital Markets offers investment banking+++, debt capital markets+, bond capital markets++, equity capital markets++, financial risk management+, and fixed income sales and trading++. Fifth Third Bank, National Association provides access to investments and investment services through various subsidiaries, including Fifth Third Securities and H2C Securities Inc. Coker Capital is a division of Fifth Third Securities. Fifth Third Securities is the trade name used by Fifth Third Securities, Inc., member FINRA/SIPC, a registered broker-dealer and registered investment advisor registered with the U.S. Securities and Exchange Commission (SEC). H2C Securities Inc., member FINRA/SIPC, is a registered broker-dealer with the (SEC) and an indirect subsidiary of Fifth Third Bank, National Association. Registration does not imply a certain level of skill or training. All rights reserved. Securities and investments offered through Fifth Third Securities, Inc. and/or H2C Securities Inc.:

  • Are Not FDIC Insured
  • Offer No Bank Guarantee
  • May Lose Value
  • Are Not Insured By Any Federal Government Agency
  • Are Not A Deposit

+ Services and activities offered through Fifth Third Bank, National Association.

++ Services and activities offered through Fifth Third Securities, Inc.

+++ Services and activities offered through Fifth Third Securities, Inc. and/or H2C Securities Inc.

For more information, visit: 53.com/capitalmarkets

Credit and lending products are offered by Fifth Third Bank, National Association. Credit products are subject to credit review and approval and mutually acceptable documentation.

Posted in , ,

News Release: Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross

By on September 21, 2023

PRESS RELEASE

September 21, 2023 at 8:02 AM EDT

SAN CARLOS, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response, today announced that, as part of its ongoing efforts to lower operating expenses, the Company has entered into an agreement to terminate its lease agreement pertaining to the Company’s headquarters in San Carlos, CA, which represented approximately $13 million of annual expenditures. In addition, Herb Cross, Chief Financial Officer, will depart the Company on September 22, 2023, to pursue an external opportunity. Mr. Cross will continue to support the Company as a consultant through the first quarter of 2024. John Orwin, Chief Executive Officer of the Company, will assume the role of principal financial officer and Rick Ruiz, Vice President, Finance of the Company, will assume the role of principal accounting officer going forward.

“I’d like to thank Herb for his service to Atreca over the last five years. His experience and financial stewardship have been crucial to the management of Atreca’s operations since before our initial public offering, and we wish him luck in his future endeavors,” said Mr. Orwin. “The agreement to terminate our lease agreement dramatically reduces our ongoing operating expenses and helps to extend our cash runway through the first quarter of 2024. Alexandria Real Estate Equities has been an excellent real estate partner for Atreca and we are extremely grateful for their willingness to help us to address this significant obligation, which will facilitate the Company’s evaluation of strategic transactions.”

Under the terms of its amended lease agreement with Alexandria Real Estate Equities, Inc., Atreca will terminate its long-term lease entered into in July 2019 in exchange for aggregate consideration of approximately $5 million. Atreca will vacate the premises by November 30, 2023, and will be evaluating options for facilities sized to its current operational needs.

Mr. Ruiz joined Atreca as Vice President, Finance, in 2018, bringing over 20 years of experience in financial management. Prior to joining Atreca, Mr. Ruiz was a consultant at RoseRyan, Inc., a leading finance and accounting advisory firm.

About Atreca, Inc.

Atreca is a biopharmaceutical company developing novel antibody-based therapeutics generated by its differentiated discovery platform, with a focus on antibody-drug conjugates (ADCs). Atreca’s platform allows access to an unexplored landscape in oncology through the identification of unique antibody-target pairs generated by the human immune system during an active immune response against tumors. These antibodies provide the basis for a pipeline of first-in-class oncology programs led by APN-497444, an ADC targeting a novel tumor glycan, in addition to MAM01/ATRC-501, a clinical candidate licensed to the Bill & Melinda Gates Medical Research Institute for the prevention of malaria. For more information on Atreca, please visit www.atreca.com.

Forward-Looking Statements

This release contains statements regarding matters that are not historical facts that are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding our strategy and future plans, including statements regarding the departure of our Chief Financial Officer and his related consulting arrangement to support us through the first quarter of 2024, our ability to extend our cash runway and the timing thereof, our evaluation of strategic transactions, the agreement to terminate our lease agreement for our corporate headquarters and the expected timing thereof, and our evaluation of corporate facilities to meet our operational needs. Our actual results may differ materially from those indicated in these forward-looking statements due to risks and uncertainties related to the initiation, timing, progress and results of our research and development programs, preclinical studies, clinical trials, regulatory submissions, and other matters that are described in our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) and available on the SEC’s website at www.sec.gov, including the risk factors set forth therein. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and we undertake no obligation to update any forward-looking statement in this press release, except as required by law.

Contacts

Atreca, Inc.
Herb Cross
Chief Financial Officer
info@atreca.com

Investors and Media:
Alex Gray, 650-779-9251
agray@atreca.com

Source: Atreca, Inc.

Posted in ,

News Release: Confluent Senior Living and MorningStar Senior Living Enter into Exclusive Negotiating Agreement with the City of Tustin for a Class A Senior Living Community

By on September 20, 2023

FOR IMMEDIATE RELEASE

September 20, 2023

283,000-Square-Foot Redevelopment Anticipated to Set Gold Standard for Senior Living in Orange County

TUSTIN, Calif. – Confluent Senior Living and MorningStar Senior Living have entered into an Exclusive Negotiating Agreement (ENA) with the City of Tustin to lead the development of MorningStar at Tustin Legacy, an approximately 283,000-square-foot, large-scale senior living community. MorningStar at Tustin Legacy is anticipated to set the new gold standard for Class A, luxury senior living in Orange County, California as a community that integrates with the character of the surrounding 1,600-acre Tustin Legacy community, while delivering innovative and progressive design and technology for the seniors of today and the future.

Amidst a highly competitive bidding process among notable, national senior living developers, Confluent and MorningStar were selected by the City to enter into negotiations based on the project partners’ strong track record of programming and designing each community with purpose, and a shared commitment to becoming ingrained in the communities in which they develop. The community is anticipated to break ground in the first half of 2025.

“Our longstanding partnership with MorningStar, coupled with our collaboration with the City and project teams with local roots, has resulted in a vision that will set a new precedent for a modern and sophisticated southern California senior living environment,” said Matt Derrick, managing director of Confluent Senior Living. “In all of our pursuits, we focus on engaging with every stakeholder to ensure that the communities we develop serve not only the needs of future residents, but those of the broader neighborhood, and this unique partnership is well-positioned to accomplish exactly that.”

Drawing upon previous experience in forming successful public-private partnerships for redevelopment projects, Confluent aims to fulfill the vision of bringing this senior community to life and contribute to the diversity of high-quality residential, commercial, and retail offerings developed at Tustin Legacy.

“Tustin Legacy embodies the past, present, and future of Orange County. Confluent Senior Living and MorningStar Senior Living are well-established developers of vibrant communities for seniors and their loved ones,” said Austin Lumbard, Mayor of the City of Tustin. “The City looks forward to working with Confluent and Morningstar in the negotiations for the MorningStar at Tustin Legacy project to honor our history while providing much-needed services to Tustin, a City known for fostering a strong sense of community and caring for one another.”

MorningStar at Tustin Legacy’s main building will be situated along the Warner & Armstrong Avenue corridors. The approximately 283,000 square-foot facility features two connected buildings four (4) to five (5) stories in height over a single level of parking that will host approximately 145 independent living units, 60 assisted living units, and a secure memory care wing with 28 supportive units designed with Confluent and MorningStar’s Whole Health Standard, an innovative approach of safety and wellness design. The main buildings will be complemented by 29 adjacent single-story cottages off secondary streets of future John Johnson Way and future Veterans Way, providing independent living residents with the option to live in a detached residential setting.

Residents will have walkable access to proposed amenities in the main building such as high-end dining options, a fitness center, spa, theater, salon, art room, outdoor aquatics, rooftop pickleball, putt-putt golf, club room, among others. Structured parking will be located under the main building mass for guests. The location also provides direct access to the next phase of Tustin Legacy Park, which will ultimately connect all of Tustin Legacy.

“Our selection as the operating partner for this landmark project underscores our strong partnership with Confluent, which has led to the successful development of 15 ground-up senior living communities. We intentionally collaborate with like-minded municipal partners to drive the greatest community benefit and residual value to the spaces which we create,” said Ken Jaeger, MorningStar Founder/CEO. “MorningStar at Tustin Legacy will boast exceptional residential offerings and amenities, purposely built to increase socialization and active living for our residents and their families and be a time-tested, eye-catching neighborhood landmark for generations to come.”

MorningStar at Tustin Legacy is planned to be sustainably designed and incorporate innovative and contemporary architecture from Orange County-based architect, HPI Architecture. The community will be designed with biophilic design principles, providing a year-round connection to nature featuring indoor and outdoor spaces, lighting and landscaping selections. The project partners dedicated a focus to sustainability through water management, renewable materials, air quality and solar power generation that will also be implemented throughout the design.

During the initial nine-month ENA period, the City together with Confluent and MorningStar will negotiate a Disposition and Development Agreement (DDA) which will provide the price and terms of the transaction with the City. Confluent and MorningStar will pursue approval of entitlements for the project during the same ENA period.

About Confluent Senior Living:
Confluent Senior Living is a national developer and investor of senior projects. Confluent Senior Living partners with a variety of industry-renowned senior living operators across the U.S. An expert in developing, buying, and selling senior living communities, Confluent Senior Living has a national senior housing portfolio of award-winning communities. Confluent Senior Living is a subsidiary of Confluent Development, a Denver-based, full-service real estate investment and development firm that owns and develops ground-up commercial real estate throughout the United States. For more information, visit ConfluentSeniorLiving.com.

About MorningStar Senior Living:
An integrated developer, owner, and operator of premier retirement communities, MorningStar’s portfolio encompasses over 40 properties under operation or development representing 5,000+ units under management or in development in 11 states in the Midwest and Western United States. Offering independent living, assisted living and memory care, MorningStar is privileged to elevate life for those who taught the rest of us how to live. For more information, visit MorningStarSeniorLiving.com.

About Tustin Legacy: Tustin Legacy is a 1,600-acre master-planned community located in the City of Tustin that is being developed on land formerly known as Marine Corps Air Station (MCAS) Tustin. For more information, visit www.tustinlegacy.com.

Media Contacts:
Jillian Headrick | dovetail solutions for Confluent Senior Living
jheadrick@dovetailsolutions.com

Lorna Lee | Vice President of Marketing & Communications, MorningStar Senior Living
llee@mstarliving.com

Stephanie Najera |Communications Manager, City of Tustin
snajera@tustinca.org

Posted in , ,

News Release: Plaza Companies, Ryan Companies Sell Prominent East Valley Medical Office Building

By on September 20, 2023

QUEEN CREEK, Arizona (September 20, 2023) — One of the East Valley’s newest and most successful medical office buildings is changing ownership.

Plaza Companies and Ryan Companies have sold Ironwood Medical Pavilion on the Banner Ironwood Medical Center campus in Queen Creek to Hammes Partners in a $23.325 million transaction. Plaza Companies will remain a minority joint venture investor and will continue to provide leasing and property management services.

Ironwood Medical Center is a 60,000-square-foot, three-story Class A medical office building that was completed in September 2019. The facility is adjacent to the Banner Ironwood Medical Center, a 78-acre medical center campus at the southwest corner of Gantzel Road and Combs Roads in Queen Creek.

The adjacent Banner Ironwood Medical Center hospital and inpatient facility currently consists of approximately 248,000-square-feet with 53 beds and related support site improvements. The medical center is planned to provide for significant expansion of the hospital facility as the area demand for medical care grows in the future.

Ironwood Medical Pavilion was a finalist for the RED Awards for medical office in 2020, and the Banner Ironwood Medical Center campus has won several industry awards for its excellence.

Bill Cook and Margaret Lloyd of Plaza Companies will lead leasing efforts, while Scott Rubin of Plaza Companies will oversee property management of the facility.

“We are very pleased to complete this win-win-win transaction for all parties involved,” said Sharon Harper, Chairman and CEO of Plaza Companies. “This is an exceptional medical office property in a growing area, and we were pleased to partner with Ryan Companies to make it a reality. Hammes Partners recognizes what an exceptional asset Ironwood Medical Pavilion is and we look forward to our new partnership Hammes and a great relationship with Banner Health.”

Hammes Partners invests on behalf of institutional investors with an exclusive focus on U.S. healthcare real estate, specifically outpatient healthcare real estate where providers are increasingly providing patient care due to cost and convenience. Hammes Partners leverages deep industry experience and relationships built over 30 years of advising healthcare clients and more than 20 years of investing in healthcare real estate.

Plaza Companies’ portfolio features numerous high-profile projects including SkySong, The ASU Scottsdale Innovation Center, Park Central, VI Living Communities and the TGen Building, among others.

Plaza Companies, based in Peoria, Arizona, is an esteemed leader in the developing and managing of medical office and commercial office properties, technology and bioscience facilities, mixed-use properties and senior housing communities. Since its founding in 1982, this full-service, specialized real estate firm has established a proud portfolio stretching across the greater Phoenix area of more than 14 million square feet in properties developed, leased or managed and valued at more than $1 billion. For more information about Plaza Companies, visit ThePlazaCo.com.

 

— 30 —

Posted in , ,

News Release: $43.24M in financing secured for 86-unit assisted living and memory care community in California

By on September 20, 2023

JLL Capital Markets led financing efforts for Varenita of Westlake

SEATTLE, Sept. 20, 2023–  JLL Capital Markets announced today that it arranged $43.24 million in financing for Varenita of Westlake, an 86-unit assisted living and memory care community in Thousand Oaks, California.

JLL represented the borrower, Westlake Senior Living, Center, LLC, to secure the five-year loan from a regional bank.

The Class A community consists of 58 assisted living units and 28 memory care units across three stories with surface and underground parking. The community features a mix of predominantly one-bedroom units, with studios and two-bedroom units.

The community features a selection of on-site community amenities including designated dining rooms, a bistro, art room, a spa and salon. It also boasts a movie theatre, laundry facility, fitness center with physical and occupational therapy, wellness center, outdoor patios and walking paths.

Located at 95 Duesenberg Dr., Varenita of Westlake is located within walking distance of some of the nation’s largest retailers and less than four miles from The Oaks, an open-air and enclosed shopping center.

Varenita offers unmatched local and regional access via some of Ventura County’s most trafficked thoroughfares. It is located near the intersection of East Thousand Oaks Blvd., a major east-west artery which connects Thousand Oaks to Westlake Village, Agoura Hills, and Boardwalk Avenue, which links the community to many of its plentiful nearby amenities. Varenita is also located less than one mile from U.S. Route 101, which offers direct links to Los Angeles and Woodland Hills.

Thousand Oaks is the second-largest city in Ventura County, conveniently located between Los Angeles and Santa Barbara. This upscale community is recognized as one of the most desirable places in all of California to live, work and raise a family. A refreshing contrast from the hustle and bustle of Los Angeles, Thousand Oaks prides itself on its identity as one of the greenest cities in the county, and one of the safest cities in the US.

The JLL team was led by Director Alanna Ellis and Associate Ace Sudah.

JLL Capital Markets is a full-service global provider of capital solutions for real estate investors and occupiers. The firm’s in-depth local market and global investor knowledge delivers the best-in-class solutions for clients — whether investment sales and advisory, debt advisory, equity advisory or a recapitalization. The firm has more than 3,000 Capital Markets specialists worldwide with offices in nearly 50 countries.

For more news, videos and research resources, please visit JLL’s newsroom.

Jones Lang LaSalle Americas, Inc. (“JLL”) is a real estate broker licensed with the California Department of Real Estate, license #01223413.  

 

– ends –

 

About JLL 

For over 200 years, JLL (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500® company with annual revenue of $20.9 billion and operations in over 80 countries around the world, our more than 103,000 employees bring the power of a global platform combined with local expertise. Driven by our purpose to shape the future of real estate for a better world, we help our clients, people and communities SEE A BRIGHTER WAYSM. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.

 

Posted in , ,

News Release: Montecito Medical Acquires Medical Office Property in Milwaukee Area

By on September 20, 2023

NASHVILLE, Tenn., Sept. 20, 2023 –(BUSINESS WIRE)–Montecito Medical, a leading acquirer of medical office properties nationwide, has acquired a 12,600-square-foot medical office building in West Allis, Wisconsin.

The Lincoln Avenue Health Center building is 100% leased to Medical College of Wisconsin, a market-dominant group in the Greater Milwaukee area.

“We are delighted to acquire this well-positioned medical real estate asset and to enter into a long-term relationship with one of the region’s most respected healthcare providers,” said Rus Gudnyy, Senior Vice President of Investments at Montecito Medical.

Medical College of Wisconsin (MCW) physicians and practitioners provide primary and specialty care at many hospitals and clinics in metro Milwaukee and eastern Wisconsin. The group is part of the Froedtert & MCW health network, which includes five hospitals, one of which is a nationally ranked academic medical center. The network’s 1,700+ physicians and nearly 40 health centers and clinics draw patients from throughout the Midwest and the nation.

“We are pleased to expand our presence in Wisconsin through this acquisition in one of the fastest growing markets in the country,” said Chip Conk, CEO of Montecito Medical.

About Montecito Medical

Montecito Medical is one of the nation’s largest privately held companies specializing in healthcare-related real estate acquisitions and partnering with physicians and developers to fund development of medical real estate. The company also supports providers with a suite of AI-powered technology solutions that increase revenues, reduce costs and build physician wealth. Since 2006, Montecito has completed transactions involving more than $5 billion in medical real estate. Headquartered in Nashville, TN, the company has been named for five consecutive years as a “key influencer in healthcare real estate” by GlobeSt.com and the editors of Real Estate Forum. For more information, please visit www.montecitomac.com.

Posted in , ,

News Release: HealthPartners breaks ground on new specialty center in Woodbury

By on September 20, 2023

HealthPartners Specialty Center Woodbury will provide additional specialty care services to meet the changing health care needs of patients in Woodbury and surrounding communities

WOODBURY, Minn., Sept. 20, 2023 – HealthPartners broke ground on a new specialty center in Woodbury on Tuesday, Sept. 19. The new facility will provide additional medical and surgical specialty care to the community.

“We’ve proudly served the Woodbury community for more than 25 years, and we’re excited for this opportunity to build upon our long-standing commitment to provide high-quality, affordable primary and specialty care offerings to this growing community,” said Kate Klugherz, vice president of medical specialties at HealthPartners.

The $50.5 million project is expected to be complete by winter 2024. The 55,000-square foot, two-story facility will be located on City Place Blvd.

The specialty center is the health system’s latest addition to its widespread presence in the Woodbury area, including HealthPartners Clinic Woodbury, TRIA Orthopedic Center, Melrose Center and other specialty care clinics including eye care, plastic surgery, dermatology, dental and behavioral health.

About HealthPartners

HealthPartners is the largest consumer-governed, non-profit health care organization in the nation with a mission to improve health and well-being in partnership with members, patients and the community. For more information, visit healthpartners.com.

Posted in , , ,

News Release: Hammes Healthcare celebrates completion of Orlando Health Jewett Orthopedic Institute

By on September 20, 2023

Milwaukee, WI, September 20, 2023 – Hammes Healthcare, a leading provider of consulting and project delivery services, celebrated the completion of the Orlando Health Jewett Orthopedic Institute in downtown Orlando.

The new complex, which is now open to patients, includes a 197,170-square-foot inpatient hospital with 75 beds and 10 operating rooms (ORs); a 64,900-square-foot ambulatory surgery center comprised of 12 ORs; and a 108,600-square-foot medical office building with 67 exam rooms, outpatient rehab, retail pharmacy, imaging suite and a café.

The hospital is the first dedicated orthopedic specialty hospital in the state of Florida and is intended to serve as the premier destination orthopedic facility dedicated to the latest and safest technologies in orthopedic care.

Hammes served as project manager for the Orlando Health Jewett Orthopedic Institute, which broke ground in November 2020. Despite challenges related to the COVID pandemic, the project met its targeted August 2023 completion date. Smart patient rooms and an education and research center were additions to the project that Hammes helped successfully incorporate within the initial budget and timeline.

“Every aspect of this project from the planning phase through to construction was deliberate, carefully thought out, and well executed,” said Wade Milligan, Regional Vice President of Hammes Healthcare. “The end result is a beautiful, destination orthopedic center that embodies the vision that Orlando Health and Jewett Orthopedic Clinic set out to achieve.”

###

About Hammes Healthcare

Hammes Healthcare is a national consulting firm that provides real estate and market strategy, facility planning,

project management and development services to the healthcare industry. As a reflection of its commitment to the healthcare industry, Hammes has been recognized as one of the nation’s leading healthcare developers by Modern Healthcare’s Construction & Design Survey for 25 consecutive years—including 20 years as No. 1—and by Revista’s Outpatient Healthcare Real Estate Development Report. Headquartered in Milwaukee, Wisconsin, Hammes provides services through a network of regional offices strategically located across the United States. https://www.hammes.com/

Posted in , ,

News Release: Life sciences market poised for a comeback

By on September 19, 2023

After reset period, the resilient life sciences industry offers opportunities and bright spots for both occupiers and owners

September 19, 2023

CHICAGO, Sept. 19, 2023 – The life sciences commercial real estate market has undergone a reset this year but is well positioned to be the comeback kid as capital sources grow more confident and green shoots emerge, according to JLL’s 2023 Life Sciences Industry and Real Estate Perspective. The report explores the state of the industry and identifies trends – and opportunities – for current and future lab space demand, along with the annual ranking of the top innovation communities. Additionally, JLL Research has added two new cluster rankings that reveal the five top markets for both medical technology (medtech) and biomanufacturing.

Though current industry fundaments have slowed, demand is well positioned to rebound. The top 20 venture capital (VC) firms focused on life sciences are waiting to deploy record amounts of capital. They’ve raised over $22 billion collectively since 2021 that will soon find its way into growing startups. With ample funds to close deals, the rest of 2023 will likely see mega M&A deals for companies with top-notch science deep into their clinical trials.

“The relationship between funding rounds and startup expansion are symbiotic, driving growth throughout the biotech sector, and, while the public markets have slightly cooled off, private capital remains hopeful with record dry powder from top VCs focused on life sciences,” said Travis McCready, Head of Life Sciences, Americas Markets, JLL.

The supply landscape shifted dramatically over the past 18 months, proving how sensitive the biotech sector is to microeconomic forces. At the end of 2021, demand across the top eight markets in the U.S. was more than 25 million square feet. By mid-2023, that had fallen to just over 10 million square feet.

Still, opportunities exist for tenants and landlords. A bright spot is small biotech occupiers that have a critical need for bench space. Throughout 2023, they have been the largest seeker of new space, as opposed to mid- to late-stage companies that can pause expansion plans and operate within their current space. Sub-30,000 square foot tenants accounted for 82% of deals signed in the first half of 2023, up from the previous average of 65%.

“Established pharmaceutical companies and biotechs have the chance to strategically select long-term markets for R&D growth,” said Kevin Wayer, President, Life Sciences, Work Dynamics Division, JLL. “It’s the perfect opportunity for larger companies to analyze their real estate portfolios and facilities and make informed location choices, as well as for growing companies and startups seeking to scale. It marks a new era of strategic decision-making in the life sciences industry.”

The top life sciences innovation communities

JLL Research looked at the three main components of what comprises a successful life sciences ecosystem, which are access to talent, funding that leads to commercialization and real estate infrastructure that supports current activities and further growth.
Once again, Greater Boston (1), the San Francisco Bay Area (2) and San Diego (3) reign supreme as the top three markets for life sciences commercial real estate in the U.S. It’s taken decades for these clusters to mature and evolve. Greater DC and Baltimore, Raleigh-Durham, New Jersey, New York City, Boulder and the Northwest Corridor, Philadelphia and Seattle round out the top 10, respectively.

“The elements that are mission critical for young startups to grow are numerous, and, while the top 10 markets provide what is necessary for the discovery and clinical stages and house the highest concentration of VCs with deep industry knowledge, new markets like Los Angeles, Chicago and Houston are showing signs of significant growth and potential,” added Maddie Holmes, Senior Research Analyst, Life Sciences Industry Insight and Advisory, JLL. “These emerging clusters are attracting investments from universities, institutions, governments and industry players who recognize the importance of fostering breakthrough scientific developments.”

New rankings: Medtech and biomanufacturing markets

The life sciences industry is more than the development of new therapeutics; it involves other life-impacting scientific endeavors such as medical devices and technologies and biomanufacturing, which are key drivers of the overall industry’s evolution. The long-term growth prospects for both medtech and biomanufacturing are exceptional, and, given the significant capital investments and the pivotal role of manufacturing operations in a company’s success, choosing locations and sites with long-term value and optimal deployment is imperative.

Through complex analysis focused on variables specific to medtech and biomanufacturing, JLL Research uncovered the top five markets that show strength in these specific subsectors. Skilled talent and its growing demand, innovation measured by clinical trials and venture capital funding, and industry performance and concentration were among the evaluated factors.

For MedTech, Orange County, Calif., is the top-ranked market due to its presence of renowned academic and research institutions, support of the local government and industry associations and strong VC presence. Minneapolis-Saint Paul (2), the San Francisco Bay Area (3), Greater Boston (4) and Salt Lake City (5) comprise the remaining top clusters.

When it comes to the top biomanufacturing market, look no further than established juggernaut Raleigh-Durham. The area is uniquely positioned due to the history of large-scale biomanufacturing in and around Research Triangle Park and the outlying counties, large talent pool and three tier-one universities. Philadelphia (2), New Jersey (3), Greater Boston (4) and the San Francisco Bay Area (5) make up the top five.

“Medical device and testing companies represent a huge swath of the life sciences landscape in the U.S., and biomanufacturing is a critical piece of a therapeutic company’s lifecycle” said Mark Bruso, Research Director, New England and U.S. Life Sciences, JLL. “Markets that specialize in these fields and have high concentrations of talent are not necessarily the same as traditional R&D hubs, so it was important for us to shine a light on the strongest medtech and biomanufacturing hubs in the country for the first time.”

JLL’s vision is to reimagine the world of real estate, creating, finding, locating and operating safe and amazing spaces. JLL’s Life Sciences team of 3,000+ experienced professionals are a safe pair of hands to help biotechnology, pharmaceutical, medical devices organizations, investors and developers achieve their ambitions. JLL brings deep understanding of location analytics, project management, research advisory, financial incentives, transaction management, capital markets, real estate strategy and technology, facilities management, regulatory compliance and quality, and more. Our solutions help fuel innovation, enhance efficiency, improve financial performance and attract and retain top talent. Our team is trained and certified to operate within office and critical, regulated environments of lab and manufacturing space. To learn more, visit us.jll.com/lifesciences.

For more news, videos and research resources on JLL, please visit JLL’s newsroom.

About JLL

For over 200 years, JLL (NYSE: JLL), a leading global commercial real estate and investment management company, has helped clients buy, build, occupy, manage and invest in a variety of commercial, industrial, hotel, residential and retail properties. A Fortune 500® company with annual revenue of $20.9 billion and operations in over 80 countries around the world, our more than 103,000 employees bring the power of a global platform combined with local expertise. Driven by our purpose to shape the future of real estate for a better world, we help our clients, people and communities SEE A BRIGHTER WAYSM. JLL is the brand name, and a registered trademark, of Jones Lang LaSalle Incorporated. For further information, visit jll.com.

Kimberly Steele
Occupier PR
+1 713 852 3420

Posted in , ,

« PreviousNext »